Free Trial

Abrdn Healthcare Investors (NYSE:HQH) Hits New 52-Week Low - Here's What Happened

Abrdn Healthcare Investors logo with Finance background
Remove Ads

Abrdn Healthcare Investors (NYSE:HQH - Get Free Report)'s share price hit a new 52-week low during trading on Wednesday . The company traded as low as $15.75 and last traded at $15.80, with a volume of 2909 shares trading hands. The stock had previously closed at $15.85.

Abrdn Healthcare Investors Stock Down 5.9 %

The business has a 50 day moving average of $17.16 and a 200 day moving average of $17.47.

Abrdn Healthcare Investors Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Friday, February 21st were given a $0.57 dividend. The ex-dividend date was Friday, February 21st. This represents a $2.28 annualized dividend and a dividend yield of 15.37%.

Hedge Funds Weigh In On Abrdn Healthcare Investors

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Millstone Evans Group LLC bought a new stake in Abrdn Healthcare Investors during the 4th quarter valued at approximately $29,000. FNY Investment Advisers LLC purchased a new position in shares of Abrdn Healthcare Investors in the 4th quarter valued at approximately $48,000. Brown Brothers Harriman & Co. bought a new stake in shares of Abrdn Healthcare Investors during the fourth quarter valued at approximately $48,000. TD Private Client Wealth LLC purchased a new stake in Abrdn Healthcare Investors in the third quarter worth $66,000. Finally, CoreCap Advisors LLC grew its stake in Abrdn Healthcare Investors by 175.8% in the fourth quarter. CoreCap Advisors LLC now owns 7,262 shares of the financial services provider's stock worth $117,000 after purchasing an additional 4,629 shares during the period. Hedge funds and other institutional investors own 32.60% of the company's stock.

Remove Ads

About Abrdn Healthcare Investors

(Get Free Report)

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.

Featured Articles

Should You Invest $1,000 in Abrdn Healthcare Investors Right Now?

Before you consider Abrdn Healthcare Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Abrdn Healthcare Investors wasn't on the list.

While Abrdn Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Big Reasons the S&P 500 Could Soar in 2025
3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads